ABILIFY
ARIPIPRAZOLE
- Strength
- 2 mg/1
- Form
- Tablet
- Class
- Atypical Antipsychotic
Otsuka America Pharmaceutical, Inc.
ARIPIPRAZOLE
Listed by Otsuka America Pharmaceutical, Inc.
| Dosage form | Tablet |
|---|---|
| Route | Oral |
| Drug class | Atypical Antipsychotic |
| Approval route | NDA — original brand approval |
| NDC code | 59148-007 |
| FDA application | NDA021436 |
| RxNorm concept | 349490 |
| Package sizes listed | 3 |
| Marketed since | November 2002 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
ARIPIPRAZOLE
Otsuka America Pharmaceutical, Inc.
ARIPIPRAZOLE
Otsuka America Pharmaceutical, Inc.
ARIPIPRAZOLE
Otsuka America Pharmaceutical, Inc.
ARIPIPRAZOLE
Otsuka America Pharmaceutical, Inc.
ARIPIPRAZOLE
Otsuka America Pharmaceutical, Inc.
Aripiprazole
Otsuka America Pharmaceutical, Inc
Aripiprazole
Otsuka America Pharmaceutical, Inc
XLCare Pharmaceuticals, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.